Lv1
48 积分 2025-07-08 加入
RIPK2 NODs to XIAP and IBD
18天前
已完结
Discovery of Potent and Selective Receptor-Interacting Serine/Threonine Protein Kinase 2 (RIPK2) Inhibitors for the Treatment of Inflammatory Bowel Diseases (IBDs)
1个月前
已完结
4-Anilinoquinazoline Derivatives as the First Potent NOD1-RIPK2 Signaling Pathway Inhibitors at the Nanomolar Range
2个月前
已完结
Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
4个月前
已完结
Discovery of Potent and Balanced Dual RIPK2 and 3 Inhibitors as a New Strategy for the Treatment of Inflammatory Bowel Diseases
4个月前
已完结
The global burden of inflammatory bowel disease: from 2025 to 2045
5个月前
已完结
IL4I1 enhances PD-L1 expression through JAK/STAT signaling pathway in lung adenocarcinoma
6个月前
已完结
The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages
6个月前
已完结
Discovery of Potent and Balanced Dual RIPK2 and 3 Inhibitors as a New Strategy for the Treatment of Inflammatory Bowel Diseases
6个月前
已完结
Identification of inhibitors of the immunosuppressive enzyme IL4I1
8个月前
已完结
皖公网安备34019202002308
